For research use only. Not for therapeutic Use.
Bremelanotide Acetate(Cat No.:I002042)is a synthetic peptide used to treat hypoactive sexual desire disorder (HSDD) in premenopausal women. It works by activating melanocortin receptors, which influence sexual arousal pathways in the brain. Administered via subcutaneous injection, Bremelanotide Acetate enhances sexual desire and reduces distress associated with low libido. Its unique mechanism of action offers an alternative to traditional hormone-based therapies, providing a targeted approach to managing HSDD. Bremelanotide Acetate represents a significant advancement in women’s sexual health, offering hope for improved quality of life and well-being.
Catalog Number | I002042 |
CAS Number | 1607799-13-2 |
Molecular Formula | C52H72N14O12 |
Purity | ≥95% |
Documentation | |
Target | melanocortin |
Solubility | DMSO: ≥ 36 mg/mL |
Storage | Store at -20°C |
IUPAC Name | (3S,6S,9R,12S,15S,23S)-15-[[(2S)-2-acetamidohexanoyl]amino]-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexazacyclotricosane-23-carboxylic acid;acetic acid |
InChI | InChI=1S/C50H68N14O10.C2H4O2/c1-3-4-16-35(58-29(2)65)43(67)64-41-25-42(66)54-20-11-10-18-37(49(73)74)60-46(70)39(23-31-26-56-34-17-9-8-15-33(31)34)62-44(68)36(19-12-21-55-50(51)52)59-45(69)38(22-30-13-6-5-7-14-30)61-47(71)40(63-48(41)72)24-32-27-53-28-57-32;1-2(3)4/h5-9,13-15,17,26-28,35-41,56H,3-4,10-12,16,18-25H2,1-2H3,(H,53,57)(H,54,66)(H,58,65)(H,59,69)(H,60,70)(H,61,71)(H,62,68)(H,63,72)(H,64,67)(H,73,74)(H4,51,52,55);1H3,(H,3,4)/t35-,36-,37-,38+,39-,40-,41-;/m0./s1 |
InChIKey | MAYUSRUHXFWITM-GBRHMYBBSA-N |
SMILES | CCCCC(C(=O)NC1CC(=O)NCCCCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CC2=CN=CN2)CC3=CC=CC=C3)CCCN=C(N)N)CC4=CNC5=CC=CC=C54)C(=O)O)NC(=O)C.CC(=O)O |